---
title: "12 Health Care Stocks Moving In Friday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302133001.md"
description: "On Friday, several healthcare stocks experienced significant intraday volatility. Gainers included Marker Therapeutics (+21.2%), Alaunos Therapeutics (+16.56%), and Cryo-Cell International (+15.89%). Conversely, major losers featured MDxHealth (-63.5%), Fractyl Health (-58.39%), and Curis (-21.26%). The data covers market cap changes and price movements for these specific equities during the regular session."
datetime: "2026-10-16T17:05:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302133001.md)
  - [en](https://longbridge.com/en/news/302133001.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302133001.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Friday's Intraday Session

### Gainers

-   **Marker Therapeutics** (NASDAQ:MRKR) stock increased by 21.2% to $1.11 during Friday's regular session. The market value of their outstanding shares is at $14.8 million.
-   **Alaunos Therapeutics** (NASDAQ:TCRT) shares moved upwards by 16.56% to $2.54. The market value of their outstanding shares is at $5.2 million.
-   **Cryo-Cell International** (AMEX:CCEL) shares moved upwards by 15.89% to $4.23. The market value of their outstanding shares is at $33.4 million.
-   **CytoSorbents** (NASDAQ:CTSO) shares moved upwards by 14.37% to $3.5. The market value of their outstanding shares is at $9.7 million.
-   **Actuate Therapeutics** (NASDAQ:ACTU) stock moved upwards by 12.3% to $0.56. The company's market cap stands at $10.4 million.
-   **ALX Oncology Holdings** (NASDAQ:ALXO) stock moved upwards by 11.0% to $1.11. The market value of their outstanding shares is at $120.3 million.

### Losers

-   **MDxHealth** (NASDAQ:MDXH) stock decreased by 63.5% to $0.22 during Friday's regular session. The company's market cap stands at $60.2 million.
-   **Fractyl Health** (NASDAQ:GUTS) shares declined by 58.39% to $1.73. The market value of their outstanding shares is at $54.1 million.
-   **Curis** (NASDAQ:CRIS) stock declined by 21.26% to $0.4. The company's market cap stands at $1.4 million.
-   **Jaguar Health** (NASDAQ:JAGX) shares fell 19.4% to $3.7. The company's market cap stands at $2.1 million.
-   **Advanced Biomed** (NASDAQ:ADVB) shares decreased by 18.04% to $4.0. The market value of their outstanding shares is at $8.4 million. As per the press release, Q4 earnings came out 3 days ago.
-   **Pomdoctor** (NASDAQ:POM) stock declined by 18.01% to $0.58. The market value of their outstanding shares is at $5.9 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [CCEL.US](https://longbridge.com/en/quote/CCEL.US.md)
- [CRIS.US](https://longbridge.com/en/quote/CRIS.US.md)
- [GUTS.US](https://longbridge.com/en/quote/GUTS.US.md)
- [MDXH.US](https://longbridge.com/en/quote/MDXH.US.md)
- [MRKR.US](https://longbridge.com/en/quote/MRKR.US.md)
- [TCRT.US](https://longbridge.com/en/quote/TCRT.US.md)
- [ACTU.US](https://longbridge.com/en/quote/ACTU.US.md)
- [ADVB.US](https://longbridge.com/en/quote/ADVB.US.md)
- [ALXO.US](https://longbridge.com/en/quote/ALXO.US.md)
- [CTSO.US](https://longbridge.com/en/quote/CTSO.US.md)
- [JAGX.US](https://longbridge.com/en/quote/JAGX.US.md)
- [POM.US](https://longbridge.com/en/quote/POM.US.md)

## Related News & Research

- [Curis prices $8.5M private placement offering](https://longbridge.com/en/news/302110075.md)
- [Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics | TCRT Stock News](https://longbridge.com/en/news/301727829.md)
- [Alaunos Acquires Velaris and Secures Major Financing](https://longbridge.com/en/news/301727995.md)
- [Paragon Labs Expands Leadership Team with Former Apogee Executives; Velaris Therapeutics Acquired by Alaunos Therapeutics, Inc.](https://longbridge.com/en/news/301699989.md)
- [CRYO CELL INTERNATIONAL 3Q FY2026: Revenue $7.82M, 10-Q Summary](https://longbridge.com/en/news/301438966.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**